Legion Partners Asset Management, LLC bought $6.0M of Lifecore Biomedical, Inc. \de\ (LFCR)

Executed Oct 3 2024, disclosed Oct 7 2024, 4 days later.

Value, as filed

$6.0M

1,463,414 sh across 2 lots

Executed

Oct 3 2024

the trade date, as filed

Disclosed

Oct 7 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+10.1%

+15.2% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 7 2024), the stock returned +10.1% (delay-adjusted); from the execution session (Oct 3 2024), +15.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

LL Legion Partners Asset Management, LLC Director profile →

Legion Partners Asset Management, LLC (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in LFCR. Across 1 priced purchase filing, the average 21-session return was +15.2% from execution and +10.1% from disclosure (delay-adjusted; derived). The largest single filing was $6.0M of LFCR (1,463,414 sh across 2 lots, as filed), executed Oct 3 2024.

The name

LFCR LFCR LFCR · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→